What factors contribute to the stigma surrounding cannabinoid use in clinical practice?
What factors contribute to the stigma surrounding cannabinoid use in clinical practice? Several factors contribute to the stigma surrounding cannabinoid use in clinical practice, including historical perceptions of cannabis as a recreational drug and a lack of comprehensive education among healthcare providers. Cultural beliefs and societal norms regarding drug use can lead to negative stereotypes associated with cannabis users, creating reluctance among clinicians to recommend cannabinoid therapies. Additionally, inconsistent legal status and varying regulations around cannabis can create uncertainty and hesitation among providers. Limited research on cannabinoids compared to conventional pharmaceuticals may also contribute to skepticism regarding their safety and efficacy. Addressing these factors through education, advocacy, and the dissemination of evidence-based research can help reduce stigma and promote acceptance of cannabinoid therapies in clinical practice (Cohen et al., 2021).